Skip to content
Search

Latest Stories

Vijay wraps up 'Leo' shoot, next one with Venkat Prabhu

The project marks a reunion between Vijay and filmmaker Lokesh Kanagaraj after the 2021 blockbuster Master.

Vijay wraps up 'Leo' shoot, next one with Venkat Prabhu

Superstar 'Thalapathy' Vijay has completed shooting for his upcoming Tamil movie Leo. The project marks a reunion between Vijay and filmmaker Lokesh Kanagaraj after the 2021 blockbuster Master.

The director shared the news on Twitter on Monday evening, posting a picture with the 49-year-old actor.


"And it's a wrap for our @actorvijay portion! Thank you for making the second outing yet again a special one na! #Leo" Kanagaraj wrote.

Last month, Kanagaraj and his team had unveiled a poster of the much-awaited movie to celebrate Vijay's 49th birthday. They also released the Tamil movie's first song "Naa Ready".

Actor Trisha Krishnan, who earlier worked with Vijay in Tamil hits Ghilli, Kuruvi, Thirupaachi, and Aathi, features opposite the actor in the film.

Bollywood star Sanjay Dutt also stars in Leo, which marks his Tamil debut.

Arjun Sarja, Mansoor Ali Khan, Priya Anand, Mysskin and Gautham Vasudev Menon round out the cast of Leo.

Anirudh Ravichander, who composed music for hit films starring Vijay such as Kaththi, Master, and Beast, is scoring the soundtrack of the movie produced by SS Lalit Kumar.

Besides Leo, Vijay has another movie in the pipeline.

In May, Vijay had confirmed that he will be working with filmmaker Venkat Prabu for an untitled movie, which marks his 68th big-screen effort.

Prabhu will be directing the film, backed by AGS Entertainment, from his own script.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less